How do you factor time from past cytotoxic chemotherapy exposure into diagnosing therapy-related AML?
Many patients have had prior chemotherapy exposure with newly diagnosed AML that may not have classic therapy-related cytogenetics. How do you approach this scenario?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Memorial Sloan Kettering Cancer Center in New York
Answered on
The WHO criteria do not specify a defined time criteria for the diagnosis of therapy-related AML. WHO writes, "Most cases of t-AML present within 10 years of the most recent exposure, and the origin of AML in cases with very long latent periods may be unrelated to therapy." But even if a patient pre...
Join for free or sign in to see the full answer